Transcriptome based individualized therapy of refractory pediatric sarcomas: feasibility, tolerability and efficacy

Bushra Weidenbusch1, Günther H S Richter1,2, Marie Sophie Kesper1,2

  • 1Department of Pediatrics and Children's Cancer Research Center, Kinderklinik München Schwabing, Klinikum rechts der Isar, Fakultät für Medizin, Technische Universität München, Munich, Germany.

Oncotarget
|May 15, 2018
PubMed

Insights

Gene expression profiling identified actionable targets in pediatric sarcomas. Targeted therapy significantly improved overall survival and progression-free survival in refractory cases, showing promise for future treatment strategies.

Area of Science:

  • Pediatric Oncology
  • Molecular Diagnostics
  • Cancer Therapeutics

Background:

  • Pediatric sarcoma survival rates have plateaued, particularly for adolescents and young adults (AYAs).
  • Refractory cases require novel treatment strategies beyond conventional therapies.
  • Gene expression profiling offers a method to characterize tumor transcriptomes and guide personalized treatment.

Purpose of the Study:

  • To assess the feasibility and efficacy of expression-based targeted therapy (TT) in pediatric sarcoma patients.
  • To identify actionable molecular targets in refractory pediatric sarcomas using gene expression profiling.
  • To compare outcomes, including survival and adverse events, between patients receiving TT and those not.

Main Methods:

  • Array-based gene expression profiling was performed on tumor biopsies from 20 pediatric sarcoma patients (ages 8-35).
  • Actionable targets and deregulated pathways were identified to guide individualized TT selection.
  • Patients receiving TT were compared to a control group (non TT) regarding disease status, survival, adverse events (AEs), and quality of life (QOL).

Main Results:

  • Actionable targets were identified in all analyzed pediatric sarcoma biopsies.
  • Nine patients received TT, while eleven did not; no significant differences in risk factors were observed between groups.
  • TT significantly improved overall survival (OS) and progression-free survival (PFS) compared to non TT (median OS: 8.83 vs. 4.93 months; median PFS: 6.17 vs. 1.6 months).
  • Quality of life (QOL) did not differ between groups. TT patients experienced fewer grade 1 AEs, with no difference in grade 2-4 AEs.

Conclusions:

  • Expression-based targeted therapy is a feasible approach for refractory pediatric sarcomas.
  • Targeted therapy demonstrated significant survival benefits in this patient cohort.
  • Further investigation is warranted to confirm the efficacy and benefits of targeted therapy in pediatric sarcoma treatment.

Related Concept Videos

Self-Efficacy01:29

Self-Efficacy

Self-efficacy is the belief in one's capacity to organize and execute actions necessary to manage prospective situations. This belief significantly influences how individuals approach goals, tasks, and challenges across different domains of life.Psychological and Educational ImpactsIndividuals with strong self-efficacy are more resilient in the face of difficulties. They are more likely to adopt effective problem-solving strategies, persist through obstacles, and regulate emotions such as...
234
Impact of Individuals on Individuals01:30

Impact of Individuals on Individuals

Human behavior is intricately shaped by social influences that arise from interactions with others in diverse contexts. These influences not only mold beliefs and attitudes but also drive the regulation of behaviors through both direct communication and observational learning. The study of these processes falls within the domain of social psychology, which seeks to understand how individuals are affected by and affect those around them.Mechanisms of Social InfluenceDirect social influence...
403
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.4K
Impact of Groups on Individuals01:28

Impact of Groups on Individuals

Groups play a fundamental role in shaping individual behavior, as they establish norms that guide interactions and decision-making. Social psychology examines how individuals conform to group expectations, often adjusting their attitudes and actions to align with group norms. These norms can be formal, such as workplace policies, or informal, such as unspoken social expectations within a fraternity.Conformity and Social InfluenceConformity arises when individuals modify their behaviors or...
371
Impact of Individuals on a Group01:25

Impact of Individuals on a Group

In social psychology, the interplay between individuals and groups is a central concern, particularly regarding how individual actions and characteristics influence group processes and outcomes. While much research emphasizes the group's power in shaping individual behavior, it is equally significant to understand how individuals contribute to the functioning, development, and success of groups.Individual Roles in Group Productivity and Decision-MakingIndividuals are not passive participants in...
338